299 related articles for article (PubMed ID: 21440549)
1. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.
Yang H; Li TW; Peng J; Tang X; Ko KS; Xia M; Aller MA
Gastroenterology; 2011 Jul; 141(1):378-88, 388.e1-4. PubMed ID: 21440549
[TBL] [Abstract][Full Text] [Related]
2. Myc, Max, and Mnt: molecular mechanisms of enhancement of cholangiocarcinogenesis by cholestasis.
Nakamura I; Roberts LR
Gastroenterology; 2011 Jul; 141(1):32-4. PubMed ID: 21620848
[No Abstract] [Full Text] [Related]
3. Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytes.
Yang H; Li TW; Ko KS; Xia M; Lu SC
Hepatology; 2009 Mar; 49(3):860-70. PubMed ID: 19086036
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
5. Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression.
Huang CK; Aihara A; Iwagami Y; Yu T; Carlson R; Koga H; Kim M; Zou J; Casulli S; Wands JR
Cancer Lett; 2016 Sep; 380(1):153-62. PubMed ID: 27364974
[TBL] [Abstract][Full Text] [Related]
6. Deregulated methionine adenosyltransferase α1, c-Myc, and Maf proteins together promote cholangiocarcinoma growth in mice and humans(‡).
Yang H; Liu T; Wang J; Li TW; Fan W; Peng H; Krishnan A; Gores GJ; Mato JM; Lu SC
Hepatology; 2016 Aug; 64(2):439-55. PubMed ID: 26969892
[TBL] [Abstract][Full Text] [Related]
7. Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells.
Fan W; Yang H; Liu T; Wang J; Li TW; Mavila N; Tang Y; Yang J; Peng H; Tu J; Annamalai A; Noureddin M; Krishnan A; Gores GJ; Martínez-Chantar ML; Mato JM; Lu SC
Hepatology; 2017 Apr; 65(4):1249-1266. PubMed ID: 27981602
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT.
Zhang Z; Sun H; Dai H; Walsh RM; Imakura M; Schelter J; Burchard J; Dai X; Chang AN; Diaz RL; Marszalek JR; Bartz SR; Carleton M; Cleary MA; Linsley PS; Grandori C
Cell Cycle; 2009 Sep; 8(17):2756-68. PubMed ID: 19652553
[TBL] [Abstract][Full Text] [Related]
9. CircRTN4IP1 regulates the malignant progression of intrahepatic cholangiocarcinoma by sponging miR-541-5p to induce HIF1A production.
Tang J; Wang R; Tang R; Gu P; Han J; Huang W
Pathol Res Pract; 2022 Feb; 230():153732. PubMed ID: 34974242
[TBL] [Abstract][Full Text] [Related]
10. MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression.
Li J; Tian F; Li D; Chen J; Jiang P; Zheng S; Li X; Wang S
FEBS Lett; 2014 Sep; 588(18):3491-500. PubMed ID: 25131931
[TBL] [Abstract][Full Text] [Related]
11. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells.
Silakit R; Kitirat Y; Thongchot S; Loilome W; Techasen A; Ungarreevittaya P; Khuntikeo N; Yongvanit P; Yang JH; Kim NH; Yook JI; Namwat N
PLoS One; 2018; 13(6):e0199827. PubMed ID: 29953500
[TBL] [Abstract][Full Text] [Related]
12. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
[TBL] [Abstract][Full Text] [Related]
13. MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma.
Xiong X; Sun D; Chai H; Shan W; Yu Y; Pu L; Cheng F
Biochem Biophys Res Commun; 2015 Sep; 465(2):262-9. PubMed ID: 26255969
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
[TBL] [Abstract][Full Text] [Related]
15. CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma.
Qi Y; Wang D; Huang W; Wang B; Huang D; Xiong F; Chen X; Chen Y
J Exp Clin Cancer Res; 2019 Oct; 38(1):413. PubMed ID: 31590696
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression.
Yao L; Han C; Song K; Zhang J; Lim K; Wu T
Cancer Res; 2015 Apr; 75(7):1388-98. PubMed ID: 25691459
[TBL] [Abstract][Full Text] [Related]
17. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
[TBL] [Abstract][Full Text] [Related]
18. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity.
Gordan JD; Bertout JA; Hu CJ; Diehl JA; Simon MC
Cancer Cell; 2007 Apr; 11(4):335-47. PubMed ID: 17418410
[TBL] [Abstract][Full Text] [Related]
19. Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
Peng F; Jiang J; Yu Y; Tian R; Guo X; Li X; Shen M; Xu M; Zhu F; Shi C; Hu J; Wang M; Qin R
Br J Cancer; 2013 Dec; 109(12):3092-104. PubMed ID: 24169343
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]